 | Up a level |
Herling, Carmen D., Coombes, Kevin R., Benner, Axel, Bloehdorn, Johannes, Barron, Lynn L., Abrams, Zachary B., Majewski, Tadeusz, Bondaruk, Jolanta E., Bahlo, Jasmin, Fischer, Kirsten, Hallek, Michael, Stilgenbauer, Stephan, Czerniak, Bogdan A., Oakes, Christopher C., Ferrajoli, Alessandra, Keating, Michael J. and Abruzzo, Lynne V. (2019). Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. Lancet Oncol., 20 (11). S. 1576 - 1587. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
Zucker, Mark R., Abruzzo, Lynne, V, Herling, Carmen D., Barron, Lynn L., Keating, Michael J., Abrams, Zachary B., Heerema, Nyla and Coombes, Kevin R. (2019). Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing. Bioinformatics, 35 (17). S. 2924 - 2932. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2059